Monday, an East Texas jury awarded $1.67 billion for infringing a single patent: 7,070,775 , which Centocor and New York University own. '775 claims an antibody or antigen-binding fragment. The patent applies to an arthritis drug. Abbott was the infringing party. $1.17 billion was for lost profits, plus $504 million for reasonable royalty damages. Abbott continues to swear non-infringement. The infringing product, Humira , sold more than $4.5 billion in 2008, Abbott's top seller, acco